Literature DB >> 13130457

Interferon-alpha: a new target for therapy in systemic lupus erythematosus?

Mary K Crow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 13130457     DOI： 10.1002/art.11226

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  17 in total

1.  Interferon-alpha: a therapeutic target in systemic lupus erythematosus.

Authors:  Mary K Crow
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

2.  Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus.

Authors:  Alyssa M Morimoto; Donna Thibault Flesher; Jihong Yang; Kristen Wolslegel; Xiangdan Wang; Ann Brady; Alexander R Abbas; Valerie Quarmby; Eric Wakshull; Bruce Richardson; Michael J Townsend; Timothy W Behrens
Journal:  Arthritis Rheum       Date:  2011-08

Review 3.  Type I interferon in organ-targeted autoimmune and inflammatory diseases.

Authors:  Mary K Crow
Journal:  Arthritis Res Ther       Date:  2010-08-25       Impact factor: 5.156

4.  Agrin signalling contributes to cell activation and is overexpressed in T lymphocytes from lupus patients.

Authors:  Elizabeth C Jury; Jillian Eldridge; David A Isenberg; Panagiotis S Kabouridis
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

5.  Association of STAT4 rs7574865 with susceptibility to systemic lupus erythematosus in Iranian population.

Authors:  Sedigheh Mirkazemi; Mahmoud Akbarian; Ahmad Reza Jamshidi; Reza Mansouri; Shima Ghoroghi; Yahya Salimi; Zahra Tahmasebi; Mahdi Mahmoudi
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

Review 6.  Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms.

Authors:  Xiaoyu Hu; Soumya D Chakravarty; Lionel B Ivashkiv
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

Review 7.  Autoantibodies in systemic lupus erythematosus.

Authors:  Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2011-12-23       Impact factor: 3.651

Review 8.  Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus.

Authors:  Yihong Yao; Brandon W Higgs; Laura Richman; Barbara White; Bahija Jallal
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156

9.  Effects of IRF5 lupus risk haplotype on pathways predicted to influence B cell functions.

Authors:  Joel M Guthridge; Daniel N Clark; Amanda Templeton; Nicolas Dominguez; Rufei Lu; Gabriel S Vidal; Jennifer A Kelly; Kenneth M Kauffman; John B Harley; Patrick M Gaffney; Judith A James; Brian D Poole
Journal:  J Biomed Biotechnol       Date:  2012-02-22

10.  Toll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1.

Authors:  Robert M Valente; Erica Ehlers; Dongsheng Xu; Humera Ahmad; Andrew Steadman; Laura Blasnitz; You Zhou; Lisa Kastanek; Bin Meng; Luwen Zhang
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.